casno. : CAS 5593-20-4
|Chinese Name||Betamethasone Dipropionate|
Chronic eczema usually develops from acute eczema or subacute eczema. At first, there is no obvious clinical symptom, but patients often scratch and rub, and gradually develop into chronic eczema. Glucocorticoids are widely used in the treatment of chronic eczema, and have achieved good clinical results. There are differences in the clinical effects of different types of glucocorticoids in the treatment of chronic eczema. Drug therapy is the main treatment of chronic eczema, in which glucocorticoids play an important role. However, there are many kinds of glucocorticoids, and different types of glucocorticoids may have different therapeutic effects. Betamethasone dipropionate can effectively inhibit the inflammatory reaction of the skin lesions and reduce the vascular permeability of the application site. Betamethasone dipropionate is produced by betamethasone and two propionic acid molecules in esterification reaction. It belongs to organic acid drugs. When applied to the lesions, the drug molecules can have a good affinity with the skin and a strong penetration ability to the skin tissue, which is more conducive to inhibiting the inflammatory reaction and immune reaction of the skin lesions.